128 results on '"Buzdar A"'
Search Results
2. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole
3. Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
4. Which threshold for ER positivity? a retrospective study based on 9639 patients
5. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
6. Using Multiple Targeted Therapies in Oncology: Considerations for Use, and Progress to Date in Breast Cancer
7. TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression
8. Randomized double-blind phase 2 trial of 3 doses of TAS-108 in patients with advanced or metastatic postmenopausal breast cancer
9. The sequential use of endocrine treatment for advanced breast cancer: where are we?
10. Plasma MicroRNA 210 Levels Correlate With Sensitivity to Trastuzumab and Tumor Presence in Breast Cancer Patients†‡
11. Ensuring Quality Cancer Care†: A Follow-up Review of the Institute of Medicineʼs 10 Recommendations for Improving the Quality of Cancer Care in America
12. Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer
13. Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer
14. Screening for Cardiac Risk Before Anthracycline Administration: What Are The Real Benefits?
15. Usage of erythropoiesis-stimulating agents in cancer patients at an academic cancer center and experience with specific care management tools for anemia
16. Predictive algorithms for adjuvant therapy: TransATAC
17. Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast
18. Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
19. Cytologically Proven Axillary Lymph Node Metastases Are Eradicated in Patients Receiving Preoperative Chemotherapy With Concurrent Trastuzumab for HER2-Positive Breast Cancer
20. A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer
21. A Phase II Neoadjuvant Trial of Sequential Nanoparticle Albumin-Bound Paclitaxel Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide in Locally Advanced Breast Cancer
22. Chemical and biological characterization of siderophore produced by the marine-derived Aureobasidium pullulans HN6.2 and its antibacterial activity
23. Endocrine-therapy-related symptoms and breast cancer
24. Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer
25. Clinical features associated with a favorable outcome following neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger
26. Using Response to Primary Chemotherapy to Select Postoperative Therapy: Long-Term Results from a Prospective Phase II Trial in Locally Advanced Primary Breast Cancer
27. Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab
28. Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
29. Clinical Experience with Epothilones in Patients with Breast Cancer
30. Summary of Aromatase Inhibitor Clinical Trials in Postmenopausal Women With Early Breast Cancer
31. Endocrine and Targeted Manipulation of Breast Cancer: Summary Statement for The Sixth Cambridge Conference
32. Preoperative chemotherapy treatment of breast cancer—A review
33. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
34. Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease
35. Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: A retrospective review of the M. D. Anderson experience
36. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers
37. Kinetics of Serum Her-2/Neu Changes in Patients With Her-2-Positive Primary Breast Cancer After Initiation of Primary Chemotherapy
38. Novel Clinical Trial Designs for Treatment of Ductal Carcinoma In Situ of the Breast with Trastuzumab (Herceptin)
39. the Safety of Breast-Conserving Surgery in Patients Who Achieve A Complete Pathologic Response After Neoadjuvant Chemotherapy
40. Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer
41. Impact of Chemotherapy Regimens Prior to Endocrine Therapy: Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial
42. Topoisomerase IIα Gene Amplification and Response to Anthracycline-Containing Adjuvant Chemotherapy in Breast Cancer
43. Anastrozole for breast cancer: recent advances and ongoing challenges
44. Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma: Follow-up at 12 years
45. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial
46. St Gallen guidelines: aromatase inhibitors recommended by name for adjuvant therapy
47. Letrozole or Tamoxifen in Early Breast Cancer
48. Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Status: An Independent Influence on the Efficacy of Endocrine Therapy in Breast Cancer?
49. Prognostic Value of Pathologic Complete Response After Primary Chemotherapy in Relation to Hormone Receptor Status and Other Factors
50. Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.